» The initial experiment testing the HSC treatment was done in Honduras.
» Naughton says there were no safety issues “clinically or histologically.”
» She says Histogen is expected to report results from a 1-year follow-up of
» the Honduras study by the end of this month [January 2010], and the one-year data will be
» submitted to the International Society of Hair Restoration Surgery’s
» professional journal.
» Source: Informa Connect - Know more, do more, be more.
» Did you see?
» There are some little news!
»
»
» Upcoming Events
»
» Hilton Head - “Regenerative Medicine: Advancing to Next Generation
» Therapies”
» March 10-14. 2010
» Hilton Head Island, SC
» Histogen to present: “Clinical Evaluation of Fibroblast-Secreted Proteins
» to Induce Hair Growth in Humans”, “Evaluation of a Bioengineered Human
» Extracellular Matrix for Wound Healing Applications”, “Hypoxic Culture
» Conditions Induce Stem Cell Marker Expression in Human Dermal Fibroblasts”
The Annual Hilton Head Workshop
Regenerative Medicine - Advancing Next Generation Therapies March 10-14, 2010
Hilton Head Island, SC
Thursday, March 11, 2010
2:25pm - Gail Naughton [Histogen] - Clinical Evaluation of Fibroblast-Secreted Proteins to Induce Hair Growth in Humans
Friday, March 12, 2010
11:45am - Stephen F. Badylak [ACell] - Epimorphic Regeneration: A Truly “Regenerative Medicine” Approach to Tissue and Organ Replacement
Now I’m waiting for a brief report (summary, outcome etc) about this Workshop …
They removed the old information/initial presentation aim:
Upcoming Events
Hilton Head - “Regenerative Medicine: Advancing to Next Generation Therapies”
March 10-14. 2010
Hilton Head Island, SC
Histogen to present: “Clinical Evaluation of Fibroblast-Secreted Proteins to Induce Hair Growth in Humans”, “Evaluation of a Bioengineered Human Extracellular Matrix for Wound Healing Applications”, “Hypoxic Culture Conditions Induce Stem Cell Marker Expression in Human Dermal Fibroblasts”
The removal thingy is nothing to worry, but it seems Histogen finally changend their initial presentation aim:
P1 - Oncological Activity of AaSynthetic Human Extracellular Matrix- Emmett Pinney (1); Mayra Montes-Camacho (1); Aaron Schenone (1); Robert Hoffman (2); Atsushi Suetsugua (2);Gail Naughton (1)?
P2 - Coating Polymers with a Human Extracellular Matrix (Hecm) Significantly Improves Implant Biocompatibility - Emmett Pinney (1); Sashka Dimitrievska (2); Aaron Schenone (1); Robert S. Kellar (1); Martin Bureau (2); Gail Naughton (1)
P4 - Evaluation of a Bioengineered Human Extracellular Matrix for Wound Healing Applications - Kelsea M. Hubka; Janess Mendoza; Mayra Montes-Camacho; Robert S. Kellar; Mark F. Baumgartner; Jonathan Mansbridge; Gail K. Naughton; Michael P. Zimber
P15 - Hypoxic Culture Conditions Induce Stem Cell Marker Expression in Human Dermal Fibroblasts - Michael P. Zimber; Kelsea M. Hubka; Frank Ziegler; Robert S. Kellar; Mark F. Baumgartner; Jonathan N. Mansbridge; Gail K. Naughton
» hmmm, seems something has changed:
» http://www.histogen.com/aboutus/news.htm#event5
»
» They removed the old information/initial presentation aim:
» ---------------
» Upcoming Events
»
» Hilton Head - “Regenerative Medicine: Advancing to Next Generation
» Therapies”
» March 10-14. 2010
» Hilton Head Island, SC
» Histogen to present: “Clinical Evaluation of Fibroblast-Secreted Proteins
» to Induce Hair Growth in Humans”, “Evaluation of a Bioengineered Human
» Extracellular Matrix for Wound Healing Applications”, “Hypoxic Culture
» Conditions Induce Stem Cell Marker Expression in Human Dermal Fibroblasts”
» ---------------
»
» The removal thingy is nothing to worry, but it seems Histogen finally
» changend their initial presentation aim:
»
» ---------------
» P1 - Oncological Activity of AaSynthetic Human Extracellular Matrix-
» Emmett Pinney (1); Mayra Montes-Camacho (1); Aaron Schenone (1); Robert
» Hoffman (2); Atsushi Suetsugua (2);Gail Naughton (1)?
»
» P2 - Coating Polymers with a Human Extracellular Matrix (Hecm)
» Significantly Improves Implant Biocompatibility - Emmett Pinney (1); Sashka
» Dimitrievska (2); Aaron Schenone (1); Robert S. Kellar (1); Martin Bureau
» (2); Gail Naughton (1)
»
» P4 - Evaluation of a Bioengineered Human Extracellular Matrix for Wound
» Healing Applications - Kelsea M. Hubka; Janess Mendoza; Mayra
» Montes-Camacho; Robert S. Kellar; Mark F. Baumgartner; Jonathan Mansbridge;
» Gail K. Naughton; Michael P. Zimber
»
» P15 - Hypoxic Culture Conditions Induce Stem Cell Marker Expression in
» Human Dermal Fibroblasts - Michael P. Zimber; Kelsea M. Hubka; Frank
» Ziegler; Robert S. Kellar; Mark F. Baumgartner; Jonathan N. Mansbridge;
» Gail K. Naughton
»
» Source:
» http://www.hiltonhead.gatech.edu/regenmed/page/poster-presentations
» ---------------
»
» Unfortunately no presentation about Histogen’s “Clinical Evaluation of
» Fibroblast-Secreted Proteins to Induce Hair Growth in Humans” … oh well
» …
Sorry guys, I just noticed a mistake, resp. the presentations above are just so called “Poster Presentations”. The “Program Presentations” resp. “Program Sessions” didn’t changed - at least it seems so …
Thursday, March 11, 2010
Session II
2:25pm - Gail Naughton - Clinical Evaluation of Fibroblast-Secreted Proteins to Induce Hair Growth in Humans
(20 min presentation) http://www.hiltonhead.gatech.edu/regenmed/page/program
That means, nothing is lost …
Edit:
Upcoming Events
Society for Investigative Dermatology (SID) Annual Meeting May 5-8, 2010
Atlanta, GA
Dr. Jonathan Mansbridge to present “Clinical Evaluation of Embryonic-like Fibroblast Secreted Proteins to Induce Hair Growth” http://www.histogen.com/aboutus/news.htm#event5
Thank you for your interest and message. We actually did not make any announcements around the Hilton Head Conference in March, however we do have some upcoming. Histogen has recently completed the 1 year follow-up of the preliminary clinical trial of HSC for hair regrowth, and will be announcing those results in April, in conjunction with the Society for Investigative Dermatology (SID) Annual Meeting.
In addition, Histogen is preparing for the start of the next clinical trial of HSC, which is scheduled to begin in Singapore late this year.
American Association for Cancer Research (AACR) Annual Meeting
April 17-21, 2010
Washington, D.C.
Emmett Pinney to present poster entitled “Coating polymers with a human extracellular matrix (hECM) significantly improves implant biocompatibility”
» They answered to me!!!
»
»
» Dear Riccardo,
»
» Thank you for your interest and message. We actually did not make any
» announcements around the Hilton Head Conference in March, however we do
» have some upcoming. …
Hmm - what? Seems Dr. Naughton is a little bit confused (and she tries to confusing me?) because they definitely announced this event on their page …
» » Did you see?
» » There are some little news!
» »
» »
» » Upcoming Events
» »
» » Hilton Head - “Regenerative Medicine: Advancing to Next Generation
» » Therapies”
» » March 10-14. 2010
» » Hilton Head Island, SC
» » Histogen to present: “Clinical Evaluation of Fibroblast-Secreted
» Proteins
» » to Induce Hair Growth in Humans”, “Evaluation of a Bioengineered Human
» » Extracellular Matrix for Wound Healing Applications”, “Hypoxic Culture
» » Conditions Induce Stem Cell Marker Expression in Human Dermal
» Fibroblasts”
»
» Yeh, good find. Here’s the link http://www.histogen.com/aboutus/news.htm
»
» Upcoming Events
»
» Hilton Head - “Regenerative Medicine: Advancing to Next Generation
» Therapies”
» March 10-14. 2010
» Hilton Head Island, SC
» Histogen to present: “Clinical Evaluation of Fibroblast-Secreted Proteins
» to Induce Hair Growth in Humans”, “Evaluation of a Bioengineered Human
» Extracellular Matrix for Wound Healing Applications”, “Hypoxic Culture
» Conditions Induce Stem Cell Marker Expression in Human Dermal Fibroblasts”
»
» American Association for Cancer Research (AACR) Annual Meeting
» April 17-21, 2010
» Washington, D.C.
» Emmett Pinney to present poster entitled “Coating polymers with a human
» extracellular matrix (hECM) significantly improves implant
» biocompatibility”
»
» Society for Investigative Dermatology (SID) Annual Meeting
» May 5-8, 2010
» Atlanta, Georgia
» Dr. Jonathan Mansbridge to present poster entitled “Clinical Evaluation of
» Embryonic-like Fibroblast Secreted Proteins to Induce Hair Growth”
Hmm - what? Seems Dr. Naughton is a little bit confused (and she tries to confusing me?) because they definitely announced this event on their page …
First Dr. Naughton doesn’t reply to general email inquires. That duty’s usually handled by Eileen Naughton Brandt (I’m assuming she’s Dr. Naughton’s daughter).
Second it sounds like their trial has-been postponed because last I heard trials were slated for the early part of 2010… that’s aggravating.
» Hmm - what? Seems Dr. Naughton is a little bit confused (and
» she tries to confusing me?) because they definitely announced this event on
» their page …
» First Dr. Naughton doesn’t reply to general email inquires. That duty’s
» usually handled by Eileen Naughton Brandt (I’m assuming she’s Dr.
» Naughton’s daughter).
»
» Second it sounds like their trial has-been postponed because last I heard
» trials were slated for the early part of 2010… that’s aggravating.
» Hmm - what? Seems Dr. Naughton is a little bit confused (and
» she tries to confusing me?) because they definitely announced this event on
» their page …
» First Dr. Naughton doesn’t reply to general email inquires. That duty’s
» usually handled by Eileen Naughton Brandt (I’m assuming she’s Dr.
» Naughton’s daughter).
»
» Second it sounds like their trial has-been postponed because last I heard
» trials were slated for the early part of 2010… that’s aggravating.
Yes I think that a little late is not a big problem, anyway I’m waiting for a good news in april…
only one week
I cross my fingers!
Poster presentations suck. I prefer posters of hot chicks.
» » hmmm, seems something has changed:
» » http://www.histogen.com/aboutus/news.htm#event5
» »
» » They removed the old information/initial presentation aim:
» » ---------------
» » Upcoming Events
» »
» » Hilton Head - “Regenerative Medicine: Advancing to Next Generation
» » Therapies”
» » March 10-14. 2010
» » Hilton Head Island, SC
» » Histogen to present: “Clinical Evaluation of Fibroblast-Secreted
» Proteins
» » to Induce Hair Growth in Humans”, “Evaluation of a Bioengineered Human
» » Extracellular Matrix for Wound Healing Applications”, “Hypoxic Culture
» » Conditions Induce Stem Cell Marker Expression in Human Dermal
» Fibroblasts”
» » ---------------
» »
» » The removal thingy is nothing to worry, but it seems Histogen finally
» » changend their initial presentation aim:
» »
» » ---------------
»
» » P1 - Oncological Activity of AaSynthetic Human Extracellular Matrix-
» » Emmett Pinney (1); Mayra Montes-Camacho (1); Aaron Schenone (1); Robert
» » Hoffman (2); Atsushi Suetsugua (2);Gail Naughton (1)?
» »
» » P2 - Coating Polymers with a Human Extracellular Matrix (Hecm)
» » Significantly Improves Implant Biocompatibility - Emmett Pinney (1);
» Sashka
» » Dimitrievska (2); Aaron Schenone (1); Robert S. Kellar (1); Martin
» Bureau
» » (2); Gail Naughton (1)
» »
» » P4 - Evaluation of a Bioengineered Human Extracellular Matrix for Wound
» » Healing Applications - Kelsea M. Hubka; Janess Mendoza; Mayra
» » Montes-Camacho; Robert S. Kellar; Mark F. Baumgartner; Jonathan
» Mansbridge;
» » Gail K. Naughton; Michael P. Zimber
» »
» » P15 - Hypoxic Culture Conditions Induce Stem Cell Marker Expression in
» » Human Dermal Fibroblasts - Michael P. Zimber; Kelsea M. Hubka; Frank
» » Ziegler; Robert S. Kellar; Mark F. Baumgartner; Jonathan N. Mansbridge;
» » Gail K. Naughton
» »
» » Source:
» » http://www.hiltonhead.gatech.edu/regenmed/page/poster-presentations
» » ---------------
» »
» » Unfortunately no presentation about Histogen’s “Clinical Evaluation of
» » Fibroblast-Secreted Proteins to Induce Hair Growth in Humans” … oh
» well
» » …
»
» Sorry guys, I just noticed a mistake, resp. the presentations above are
» just so called “Poster Presentations”. The “Program
» Presentations” resp. “Program Sessions” didn’t changed - at least it seems
» so …
»
» ---------------
» Thursday, March 11, 2010
» Session II
» 2:25pm - Gail Naughton - Clinical Evaluation of Fibroblast-Secreted
» Proteins to Induce Hair Growth in Humans
» (20 min presentation)
» http://www.hiltonhead.gatech.edu/regenmed/page/program
» ---------------
»
» That means, nothing is lost …
» --------------------------
» Edit:
» Upcoming Events
» Society for Investigative Dermatology (SID) Annual Meeting
» May 5-8, 2010
» Atlanta, GA
» Dr. Jonathan Mansbridge to present “Clinical Evaluation of Embryonic-like
» Fibroblast Secreted Proteins to Induce Hair Growth”
» http://www.histogen.com/aboutus/news.htm#event5
» Hmm - what? Seems Dr. Naughton is a little bit confused (and
» she tries to confusing me?) because they definitely announced this event on
» their page …
» First Dr. Naughton doesn’t reply to general email inquires. That duty’s
» usually handled by Eileen Naughton Brandt (I’m assuming she’s Dr.
» Naughton’s daughter).
»
» Second it sounds like their trial has-been postponed because last I heard
» trials were slated for the early part of 2010… that’s aggravating.
She said they’re completing followup to initial clinical trial, and that another is coming later this year. So, going by these words, it would mean that there has already been two trials, with one more coming. Is the one later in 2010 phase III?
» She said they’re completing followup to initial clinical trial, and that
» another is coming later this year. So, going by these words, it would mean
» that there has already been two trials, with one more coming. Is the one
» later in 2010 phase III?
Who knows. Its pretty obvious these guys are hanging on by a string. They’re going to say anything to keep the funding coming. Shades of ICX. Time to remove this one from the “serious” list of possible near-term protocols. Its Aderans or nothing for at least the next five years.
» » She said they’re completing followup to initial clinical trial, and that
» » another is coming later this year. So, going by these words, it would
» mean
» » that there has already been two trials, with one more coming. Is the
» one
» » later in 2010 phase III?
»
» Who knows. Its pretty obvious these guys are hanging on by a string.
» They’re going to say anything to keep the funding coming. Shades of ICX.
» Time to remove this one from the “serious” list of possible near-term
» protocols. Its Aderans or nothing for at least the next five years.
The sad thing is their technology worked to some degree and they got killed over some stupied lawsuit. Wish it never happened but it did. It’s really quite ridiculous when you think about it these sharks came in for no good reason except spite. It’s especailly sinister because it could have made a difference in peoples lives.
I’m not agree with you pessimism, I’ve no reason for believe that they are “hanging on by a string”.
I think their treatment works otherwise they would not have any financings
» I’m not agree with you pessimism, I’ve no reason for believe that they are
» “hanging on by a string”.
» I think their treatment works otherwise they would not have any financings
Hopfully your right though It doesn’t look good at this point. One way to be certain would be to find out if they won their case or not. That is really important and they don’t seem to want to talk about it now. Is their time in court over now, does anyone know? I emailed them about it and they haven’t answered me about it yet. Though just going to court alone “could” have bankrupted them… They also could be misleading people in hopes to get more $.
I don’t know honestly if they still do have sufficient funding right now. I swear I remeber someone saying their investors pulled out. I’m going to try and find out more searching the web.
» I don’t know honestly if they still do have sufficient funding right now.
» I swear I remeber someone saying their investors pulled out. I’m going to
» try and find out more searching the web.
2/24/09 - A patent infringement lawsuit filed last month against Histogen has triggered a funding crisis at the San Diego biomedical startup, which was forced to lay off all 36 of its employees at the end of January.
Histogen founder and CEO Gail Naughton told me this afternoon the suit filed by rival SkinMedica of Carlsbad, CA, prompted a group of angel investors to withdraw their planned $2.4 million investment in Histogen at the end of January. The ensuing funding crisis has been playing out behind the scenes at Histogen, even while Naughton reported promising findings on the startup’s experimental hair regrowth treatment last week at the 4th Annual Stem Cell Summit in New York.
Source: Informa Connect - Know more, do more, be more.
» » I don’t know honestly if they still do have sufficient funding right now.
»
» » I swear I remeber someone saying their investors pulled
» out. I’m going to
» » try and find out more searching the web.
»
» ------------
» 2/24/09 - A patent infringement lawsuit filed last month against
» Histogen has triggered a funding crisis at the San Diego biomedical
» startup, which was forced to lay off all 36 of its employees at the end of
» January.
»
» Histogen founder and CEO Gail Naughton told me this afternoon the suit
» filed by rival SkinMedica of Carlsbad, CA, prompted a group of angel
» investors to withdraw their planned $2.4 million investment in Histogen at
» the end of January. The ensuing funding crisis has been playing out
» behind the scenes at Histogen, even while Naughton reported promising
» findings on the startup’s experimental hair regrowth treatment last week at
» the 4th Annual Stem Cell Summit in New York.
» Source:
» Informa Connect - Know more, do more, be more.
» ---------------
Thanks Iron Man! I knew I read it some where, saves me the time of trying to confirm what I stated.
» » I don’t know honestly if they still do have sufficient funding right now.
»
» » I swear I remeber someone saying their investors pulled
» out. I’m going to
» » try and find out more searching the web.
»
» ------------
» 2/24/09 - A patent infringement lawsuit filed last month against
» Histogen has triggered a funding crisis at the San Diego biomedical
» startup, which was forced to lay off all 36 of its employees at the end of
» January.
»
» Histogen founder and CEO Gail Naughton told me this afternoon the suit
» filed by rival SkinMedica of Carlsbad, CA, prompted a group of angel
» investors to withdraw their planned $2.4 million investment in Histogen at
» the end of January. The ensuing funding crisis has been playing out
» behind the scenes at Histogen, even while Naughton reported promising
» findings on the startup’s experimental hair regrowth treatment last week at
» the 4th Annual Stem Cell Summit in New York.
» Source:
» Informa Connect - Know more, do more, be more.
» ---------------
This was over a year ago, the fact that they are still in business is a good sign.
» » I don’t know honestly if they still do have sufficient funding right now.
»
» » I swear I remeber someone saying their investors pulled
» out. I’m going to
» » try and find out more searching the web.
»
» ------------
» 2/24/09 - A patent infringement lawsuit filed last month against
» Histogen has triggered a funding crisis at the San Diego biomedical
» startup, which was forced to lay off all 36 of its employees at the end of
» January.
»
» Histogen founder and CEO Gail Naughton told me this afternoon the suit
» filed by rival SkinMedica of Carlsbad, CA, prompted a group of angel
» investors to withdraw their planned $2.4 million investment in Histogen at
» the end of January. The ensuing funding crisis has been playing out
» behind the scenes at Histogen, even while Naughton reported promising
» findings on the startup’s experimental hair regrowth treatment last week at
» the 4th Annual Stem Cell Summit in New York.
» Source:
» Informa Connect - Know more, do more, be more.
» ---------------
This is an advertising site for paid
advertisers to showcase successful hair restoration results only. It is not the
mandate of this site to engage in the discussion of failed, unsuccessful
procedures, lawsuits, litigations, refunds or complaint cases. Surgical hair
restoration procedures carry risks. Please do thorough research, consult your
own physician and investigate a doctor's background carefully before making a
decision. By proceeding to use our site, you agree to abide by our Terms of Use & Privacy Policy at http://hairsite.com/terms-of-use/ where you can also find a list of HairSite's sponsoring physicians.
